-
DE
F32.1 – Moderate Depressive Episode
F32.1 is the ICD-10 code for a moderate depressive episode, characterized by persistent low mood, loss of interest, fatigue, and impaired daily functioning.
Add as Preferred SourceThings worth knowing about "F32.1"
F32.1 is the ICD-10 code for a moderate depressive episode, characterized by persistent low mood, loss of interest, fatigue, and impaired daily functioning.
What is F32.1?
The ICD-10 code F32.1 refers to a moderate depressive episode. The ICD-10 (International Classification of Diseases, 10th Revision) is the globally used system for classifying medical conditions. Depressive episodes are categorized by severity: mild (F32.0), moderate (F32.1), and severe (F32.2 or F32.3). In F32.1, several characteristic depressive symptoms are present at a clinically significant level, substantially interfering with everyday life.
Causes and Risk Factors
Depressive episodes result from an interplay of multiple factors:
- Biological factors: Imbalances in neurotransmitters such as serotonin, dopamine, and noradrenaline in the brain
- Genetic predisposition: A family history of depression increases the risk
- Psychosocial factors: Stressful life events, chronic stress, loss, or trauma
- Physical illnesses: Thyroid disorders, chronic pain, or other organic causes can contribute to depressive episodes
- Personality traits: Higher neuroticism scores are associated with an increased risk of depression
Symptoms
According to ICD-10 criteria, a diagnosis of F32.1 requires at least two of the three core symptoms and at least three to four additional symptoms present for a minimum of two weeks.
Core Symptoms
- Persistent low or depressed mood
- Loss of interest and pleasure (anhedonia)
- Increased fatigue and reduced energy
Additional Symptoms
- Reduced concentration and attention
- Decreased self-esteem and self-confidence
- Feelings of guilt and worthlessness
- Pessimistic views about the future
- Sleep disturbances (difficulty falling or staying asleep, or early morning awakening)
- Changes in appetite (usually reduced appetite with weight loss)
- Psychomotor changes (slowing or agitation)
Compared to a mild depressive episode (F32.0), symptoms in F32.1 are more pronounced, and individuals typically have considerable difficulty maintaining their professional and social activities.
Diagnosis
The diagnosis of a moderate depressive episode (F32.1) is made by a physician or psychiatrist based on a thorough clinical interview (anamnesis) and the ICD-10 diagnostic criteria. There are no specific laboratory markers for depression; however, organic causes are ruled out through physical examination and blood tests (e.g., thyroid function, blood count). Standardized questionnaires such as the PHQ-9 (Patient Health Questionnaire) or the Hamilton Depression Rating Scale support the assessment of symptom severity.
Treatment
Treatment of a moderate depressive episode (F32.1) typically involves a combination of psychotherapy and, depending on severity and course, pharmacological therapy.
Psychotherapy
- Cognitive Behavioural Therapy (CBT): One of the most evidence-based treatments for depression; it helps patients identify and change negative thought patterns
- Psychodynamic Therapy: Addresses unconscious conflicts and biographical factors
- Interpersonal Therapy (IPT): Focuses on interpersonal problems and role conflicts
Pharmacological Therapy
- Antidepressants: Selective serotonin reuptake inhibitors (SSRIs) such as sertraline, escitalopram, or fluoxetine are commonly prescribed for moderate depression
- Medication should be prescribed and regularly reviewed by a physician
- Therapeutic effects typically emerge after two to four weeks
Additional Measures
- Regular physical exercise (demonstrated antidepressant effect)
- Sleep hygiene and maintaining a daily routine
- Social support and psychoeducation
- Light therapy (particularly when a seasonal component is present)
Course and Prognosis
With appropriate treatment, many individuals respond well to therapy. Without treatment, a moderate depressive episode may persist for weeks to months. The risk of relapse is elevated, which is why a sufficiently long continuation of treatment (maintenance therapy) is recommended. When episodes recur repeatedly, the diagnosis is classified as recurrent depressive disorder (F33).
References
- World Health Organization (WHO): International Classification of Diseases, 10th Revision (ICD-10), Chapter V, F32 – Depressive Episode. Geneva, 2019.
- National Institute for Health and Care Excellence (NICE): Depression in adults: treatment and management. NICE guideline NG222. London, 2022.
- American Psychiatric Association (APA): Practice Guideline for the Treatment of Patients with Major Depressive Disorder. 3rd Edition. Arlington, 2010.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Skip product gallery
Subscription available
Floral
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®30 lozenges
Regular price:
22,90 €
Discount
Subscription available
Lactoferrin 60 Capsules
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
60 Capsules
Sale price:
50,00 €
Regular price:
59,90 €
Subscription available
Multivitamin Mineral Complex
Daily basic supply: the complete spectrum of micronutrients
Natural multivitamin complex for the immune system, energy, and central body functions
30 Capsules
Regular price:
29,90 €
Subscription available
Natural Iron
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
30 Capsules
Regular price:
35,90 €